Question 20 5 pts Novavax is a clinical stage vaccine company that is developing a Vaccine for COVID-19. Novavax believes that they will be successful in developing a vaccine, which is expected to increase free cash flow by $120 million per year for the next six years. If investors had not been expecting this news, what is the most likely effect on Novavax's stock price upon the announcement, given that Novavax has 80 million shares outstanding, no debt, and an equity cost of capital of 13%? Rise by $5.15 Rise by $6,00 No effect on the price Rise by $7.12